Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

11125	Companies
245017	Keywords
173072	Articles
132116	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 01/09/2025 at 22:45, 1 year 8 months ago

Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness
Onco-Innovations Limited announces exclusive PNKP inhibitors Technology for cancer treatment, potentially improving patient outcomes

Technology Patient Outcomes Cancer Treatment PNKP Inhibitors Onco-Innovations Limited
BRIEF

published on 01/09/2025 at 01:05, 1 year 8 months ago

Onco-Innovations Secures Exclusive License for PNKP Inhibitors in Cancer Treatment

Cancer Treatment Oncology Market FDA Trials Onco-Innovations PNKP Inhibitors
BRIEF

published on 01/09/2025 at 01:05, 1 year 8 months ago

Onco-Innovations obtient une licence exclusive pour les inhibiteurs de la PNKP dans le traitement du cancer

Traitement Du Cancer Essais De La FDA Innovations Oncologiques Inhibiteurs De La PNKP Marché De L'oncologie
PRESS RELEASE

published on 01/09/2025 at 01:00, 1 year 8 months ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options
Onco-Innovations Limited announces exclusive-licensed PNKP inhibitors Technology targeting cancer cells to enhance treatment effectiveness across various cancer types including colorectal, breast, and lung cancer

Clinical Trials Cancer Treatment Oncology Market Onco-Innovations Limited PNKP Inhibitors Technology

Accesswire

Published on 10/05/2026 at 14:45, 2 hours 1 minute ago

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 2 hours 16 minutes ago

Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 2 hours 16 minutes ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 2 hours 46 minutes ago

Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 2 hours 46 minutes ago

GameSquare to Present at Upcoming Investor Conferences

View all ACCESSWIRE

EQS Group

Published on 10/05/2026 at 15:50, 56 minutes ago

EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
Published on 10/05/2026 at 15:49, 56 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior PLC
Published on 10/05/2026 at 15:47, 59 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 30.09.26.
Published on 10/05/2026 at 15:43, 1 hour 3 minutes ago

Form 8.3 - The Vanguard Group, Inc.: easyJet PLC
Published on 10/05/2026 at 15:40, 1 hour 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Vesuvius PLC

Les Echos

Published on 10/05/2026 at 16:21, 24 minutes ago

Guillemot Corporation S.A. | Weekly report share buyback from September 28 to October 2, 2026
Published on 10/05/2026 at 16:21, 24 minutes ago

Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 28 septembre au 2 octobre 2026
Published on 10/05/2026 at 15:58, 48 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 10/05/2026 at 15:00, 1 hour 46 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 10/05/2026 at 15:00, 1 hour 46 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

View all LES ECHOS COMFI WIRE